{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:10:33Z","timestamp":1779433833727,"version":"3.53.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY027134"],"award-info":[{"award-number":["R01 EY027134"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022833","name":"Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR22701\/MED\/15\/166\/2016"],"award-info":[{"award-number":["BT\/PR22701\/MED\/15\/166\/2016"]}],"id":[{"id":"10.13039\/100022833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00417-025-07036-9","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:28:00Z","timestamp":1772180880000},"page":"1753-1761","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Higher diabetes genetic load in proliferative diabetic retinopathy in South India: The South Indian GeNetics of DiAbeTic Retinopathy (SIGNATR) study"],"prefix":"10.1007","volume":"264","author":[{"given":"A. N.","family":"Rizza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Benchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehana","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Ricky","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Susarla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengtong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Yin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime E.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennet J.","family":"McComish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajya L.","family":"Gurung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Burdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinnakaruppan","family":"Mathavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Sobrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7488-250X","authenticated-orcid":false,"given":"Sudha K.","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The SIGNATR study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Brustoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Lains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Khetan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarangapani","family":"Sripriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"1","key":"7036_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2337\/db13-1592","volume":"63","author":"R Unnikrishnan","year":"2014","unstructured":"Unnikrishnan R, Anjana RM, Mohan V (2014) Diabetes in South Asians: is the phenotype different? Diabetes 63(1):53\u201355","journal-title":"Diabetes"},{"issue":"12","key":"7036_CR2","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1007\/s00125-011-2291-5","volume":"54","author":"RM Anjana","year":"2011","unstructured":"Anjana RM et al (2011) Prevalence of diabetes and prediabetes (impaired fasting glucose and\/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 54(12):3022\u20133027","journal-title":"Diabetologia"},{"issue":"4","key":"7036_CR3","first-page":"429","volume":"93","author":"P Namperumalsamy","year":"2009","unstructured":"Namperumalsamy P et al (2009) Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br J Ophthalmol 93(4):429\u2013434","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"7036_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/09286586.2017.1290257","volume":"24","author":"R Raman","year":"2017","unstructured":"Raman R et al (2017) Incidence and progression of diabetic retinopathy in urban India: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS II), report 1. Ophthalmic Epidemiol 24(5):294\u2013302","journal-title":"Ophthalmic Epidemiol"},{"issue":"1","key":"7036_CR5","doi-asserted-by":"publisher","first-page":"e000005","DOI":"10.1136\/bmjdrc-2013-000005","volume":"2","author":"R Raman","year":"2014","unstructured":"Raman R et al (2014) Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III (SN-DREAMS III), report no 2. BMJ Open Diabetes Res Care 2(1):e000005","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"7036_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000314720","volume":"45","author":"R Raman","year":"2011","unstructured":"Raman R et al (2011) Is prevalence of retinopathy related to the age of onset of diabetes? Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic report No. 5. Ophthalmic Res 45(1):36\u201341","journal-title":"Ophthalmic Res"},{"issue":"1","key":"7036_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1758-5996-3-9","volume":"3","author":"PK Rani","year":"2011","unstructured":"Rani PK et al (2011) Albuminuria and diabetic retinopathy in type 2 diabetes mellitus Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS, report 12). Diabetol Metab Syndr 3(1):9","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"7036_CR8","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1167\/iovs.05-0019","volume":"46","author":"M Rema","year":"2005","unstructured":"Rema M et al (2005) Prevalence of diabetic retinopathy in urban India: the Chennai urban rural epidemiology study (CURES) eye study, I. Invest Ophthalmol Vis Sci 46(7):2328\u20132333","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"7036_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/0301-4738.178144","volume":"64","author":"SS Gadkari","year":"2016","unstructured":"Gadkari SS, Maskati QB, Nayak BK (2016) Prevalence of diabetic retinopathy in India: the All India ophthalmological society diabetic retinopathy eye screening study 2014. Indian J Ophthalmol 64(1):38\u201344","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"7036_CR10","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1167\/iovs.07-1633","volume":"49","author":"NH Arar","year":"2008","unstructured":"Arar NH et al (2008) Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci 49(9):3839\u20133845","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"7036_CR11","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.2337\/db07-1495","volume":"57","author":"K Hietala","year":"2008","unstructured":"Hietala K et al (2008) Heritability of proliferative diabetic retinopathy. Diabetes 57(8):2176\u20132180","journal-title":"Diabetes"},{"issue":"7","key":"7036_CR12","doi-asserted-by":"publisher","first-page":"e811","DOI":"10.1111\/aos.13769","volume":"96","author":"W Meng","year":"2018","unstructured":"Meng W et al (2018) A genome-wide association study suggests new evidence for an association of the NADPH oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes. Acta Ophthalmol 96(7):e811\u2013e819","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"7036_CR13","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1038\/s41591-024-03089-1","volume":"30","author":"JH Breeyear","year":"2024","unstructured":"Breeyear JH et al (2024) Adaptive selection at G6PD and disparities in diabetes complications. Nat Med 30(9):2480\u20132488","journal-title":"Nat Med"},{"issue":"10","key":"7036_CR14","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1007\/s00125-015-3697-2","volume":"58","author":"KP Burdon","year":"2015","unstructured":"Burdon KP et al (2015) Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene. Diabetologia 58(10):2288\u20132297","journal-title":"Diabetologia"},{"key":"7036_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-019-0094-7","volume":"4","author":"C Liu","year":"2019","unstructured":"Liu C et al (2019) Genome-wide association study for proliferative diabetic retinopathy in Africans. NPJ Genom Med 4:20","journal-title":"NPJ Genom Med"},{"issue":"2","key":"7036_CR16","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2337\/db18-0567","volume":"68","author":"S Pollack","year":"2019","unstructured":"Pollack S et al (2019) Multiethnic genome-wide association study of diabetic retinopathy using liability threshold modeling of duration of diabetes and glycemic control. Diabetes 68(2):441\u2013456","journal-title":"Diabetes"},{"issue":"4","key":"7036_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamaophthalmol.2013.2299","volume":"131","author":"RH Muni","year":"2013","unstructured":"Muni RH et al (2013) Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial. JAMA Ophthalmol 131(4):514\u2013521","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"7036_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12881-018-0587-8","volume":"19","author":"PS Graham","year":"2018","unstructured":"Graham PS et al (2018) Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy. BMC Med Genet 19(1):71","journal-title":"BMC Med Genet"},{"issue":"10","key":"7036_CR19","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/hmg\/ddab067","volume":"30","author":"IS Forrest","year":"2021","unstructured":"Forrest IS et al (2021) Genome-wide polygenic risk score for retinopathy of type 2 diabetes. Hum Mol Genet 30(10):952\u2013960","journal-title":"Hum Mol Genet"},{"issue":"7","key":"7036_CR20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","volume":"52","author":"M Vujkovic","year":"2020","unstructured":"Vujkovic M et al (2020) Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet 52(7):680\u2013691","journal-title":"Nat Genet"},{"issue":"10","key":"7036_CR21","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1080\/02713683.2022.2091148","volume":"47","author":"G Susarla","year":"2022","unstructured":"Susarla G et al (2022) Younger age and albuminuria are associated with proliferative diabetic retinopathy and diabetic macular edema in the South Indian GeNetics of DiAbeTic Retinopathy (SIGNATR) study. Curr Eye Res 47(10):1389\u20131396","journal-title":"Curr Eye Res"},{"issue":"2","key":"7036_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/09286580590932734","volume":"12","author":"S Agarwal","year":"2005","unstructured":"Agarwal S et al (2005) Sankara nethralaya-diabetic retinopathy epidemiology and molecular genetic study (SN-DREAMS 1): study design and research methodology. Ophthalmic Epidemiol 12(2):143\u2013153","journal-title":"Ophthalmic Epidemiol"},{"issue":"9","key":"7036_CR23","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson CP et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110(9):1677\u20131682","journal-title":"Ophthalmology"},{"issue":"8","key":"7036_CR24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/ceo.12974","volume":"45","author":"C Sabanayagam","year":"2017","unstructured":"Sabanayagam C et al (2017) Singapore Indian Eye Study-2: methodology and impact of migration on systemic and eye outcomes. Clin Exp Ophthalmol 45(8):779\u2013789","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"7036_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ajhg.2023.01.002","volume":"110","author":"KA Broadaway","year":"2023","unstructured":"Broadaway KA et al (2023) Loci for insulin processing and secretion provide insight into type 2 diabetes risk. Am J Hum Genet 110(2):284\u2013299","journal-title":"Am J Hum Genet"},{"issue":"9","key":"7036_CR26","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41588-023-01462-3","volume":"55","author":"V Lagou","year":"2023","unstructured":"Lagou V et al (2023) GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification. Nat Genet 55(9):1448\u20131461","journal-title":"Nat Genet"},{"issue":"1","key":"7036_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s42003-022-03248-5","volume":"5","author":"M Loh","year":"2022","unstructured":"Loh M et al (2022) Identification of genetic effects underlying type 2 diabetes in South Asian and European populations. Commun Biol 5(1):329","journal-title":"Commun Biol"},{"issue":"2","key":"7036_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41588-023-01625-2","volume":"56","author":"A Oliveri","year":"2024","unstructured":"Oliveri A et al (2024) Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK biobank. Nat Genet 56(2):212\u2013221","journal-title":"Nat Genet"},{"issue":"8003","key":"7036_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","volume":"627","author":"K Suzuki","year":"2024","unstructured":"Suzuki K et al (2024) Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature 627(8003):347\u2013357","journal-title":"Nature"},{"issue":"1","key":"7036_CR30","doi-asserted-by":"publisher","first-page":"e1004876","DOI":"10.1371\/journal.pgen.1004876","volume":"11","author":"A Mahajan","year":"2015","unstructured":"Mahajan A et al (2015) Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus. PLoS Genet 11(1):e1004876","journal-title":"PLoS Genet"},{"issue":"2","key":"7036_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2337\/db22-0708","volume":"72","author":"E Chow","year":"2023","unstructured":"Chow E et al (2023) Dorzagliatin, a dual-acting glucokinase activator, increases insulin secretion and glucose sensitivity in glucokinase maturity-onset diabetes of the young and recent-onset type 2 diabetes. Diabetes 72(2):299\u2013308","journal-title":"Diabetes"},{"issue":"5","key":"7036_CR32","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s41591-022-01802-6","volume":"28","author":"D Zhu","year":"2022","unstructured":"Zhu D et al (2022) Dorzagliatin in drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med 28(5):965\u2013973","journal-title":"Nat Med"},{"key":"7036_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0036-y","volume":"4","author":"M Lu","year":"2019","unstructured":"Lu M et al (2019) Targeting growth hormone function: strategies and therapeutic applications. Signal Transduct Target Ther 4:3","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"7036_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108877","volume":"24","author":"BT Shaker","year":"2023","unstructured":"Shaker BT et al (2023) The 14-kilodalton human growth hormone fragment a potent inhibitor of angiogenesis and tumor metastasis. Int J Mol Sci 24(10):8877","journal-title":"Int J Mol Sci"},{"issue":"8","key":"7036_CR35","doi-asserted-by":"publisher","first-page":"112982","DOI":"10.1016\/j.celrep.2023.112982","volume":"42","author":"A Tworak","year":"2023","unstructured":"Tworak A et al (2023) Rapid RGR-dependent visual pigment recycling is mediated by the RPE and specialized Muller glia. Cell Rep 42(8):112982","journal-title":"Cell Rep"},{"issue":"33","key":"7036_CR36","doi-asserted-by":"publisher","first-page":"29874","DOI":"10.1074\/jbc.M503603200","volume":"280","author":"A Wenzel","year":"2005","unstructured":"Wenzel A et al (2005) The retinal G protein-coupled receptor (RGR) enhances isomerohydrolase activity independent of light. J Biol Chem 280(33):29874\u201329884","journal-title":"J Biol Chem"},{"issue":"5","key":"7036_CR37","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.3892\/mmr.2016.5847","volume":"14","author":"J Li","year":"2016","unstructured":"Li J et al (2016) RGR variants in different forms of retinal diseases: the undetermined role of truncation mutations. Mol Med Rep 14(5):4811\u20134815","journal-title":"Mol Med Rep"},{"issue":"1","key":"7036_CR38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s43856-024-00663-z","volume":"4","author":"KM Schiabor Barrett","year":"2024","unstructured":"Schiabor Barrett KM et al (2024) Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes. Commun Med (Lond) 4(1):239","journal-title":"Commun Med (Lond)"},{"issue":"1","key":"7036_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00421-w","volume":"9","author":"A Bonnefond","year":"2023","unstructured":"Bonnefond A et al (2023) Monogenic diabetes. Nat Rev Dis Primers 9(1):12","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"7036_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1210\/clinem\/dgaa710","volume":"106","author":"DT Broome","year":"2021","unstructured":"Broome DT et al (2021) Approach to the patient with MODY-monogenic diabetes. J Clin Endocrinol Metab 106(1):237\u2013250","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7036_CR41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2013.283981","volume":"311","author":"JC Florez","year":"2014","unstructured":"Florez JC (2014) Insights from monogenic diabetes and glycemic treatment goals for common types of diabetes. JAMA 311(3):249\u2013251","journal-title":"JAMA"},{"issue":"3","key":"7036_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jama.2013.283980","volume":"311","author":"AM Steele","year":"2014","unstructured":"Steele AM et al (2014) Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA 311(3):279\u2013286","journal-title":"JAMA"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07036-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-07036-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-07036-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:03:00Z","timestamp":1779433380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-07036-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7036"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-07036-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review boards of the Vision Research Foundation, Case Western Reserve University, and Mass General Brigham. All participants provided informed consent, and the research adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data and photographs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Financial Interests:\n                      A. N. Rizza receives financial support from the Department of Biotechnology, Government of India to fund this current manuscript.Penelope Benchek owns stock in Crispr Therapeutics.Ines Lains receives financial support from the NIH\/NEI (grant number K12 EY016335) and has patents for US11049227B2 and US20210116461A1.Ching-Yu Cheng receives consulting fees for Medi-Whale.Tien Yin Wong receives consulting fees for Abbvie Pte Ltd Personal, Aldropika Therapeutics, Bayer, Boehringer-Ingelheim, Carl Zeiss, Genentech, Novartis, Opthea Limited, Plano, Quaerite, Biopharm Research Ltd, Regeneron Pharmaceuticals Inc, Roche, Sanofi, and Shanghai Henlius. He is the inventor, and hold patents for start\u2010up companies EyRiS and Visre, which have interests in, and develop digital solutions for eye diseases, including diabetic retinopathy.Bennet J. McComish receives grant support from the Royal Hobart Hospital Research Foundation.Kathryn Burdon receives grant support from the National Health and Medical Research Council Australia.Sarangapani Sripriya receives financial support from the Department of Biotechnology, Government of India to fund this current manuscript.Sinnakaruppan Mathavan receives financial support from the Department of Biotechnology, Government of India to fund this current manuscript.Lucia Sobrin receives grant support from the National Eye Institute (R01 EY027134) to fund this present manuscript.Sudha K. Iyengar receives grant support from the Veterans Association Grant\u00a0(1I01BX003364-01A1) National Eye Institute (R01EY027134) to fund this present manuscript.\n                      Non-Financial Interests:\n                      The authors have no relevant non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}